These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4242816)

  • 41. [Secondary manifestations of the antibacterial therapy of tuberculosis in children].
    Frolova VM
    Probl Tuberk; 1967; 45(1):32-6. PubMed ID: 5303088
    [No Abstract]   [Full Text] [Related]  

  • 42. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 43. A comparison of two regimens of streptomycin plus PAS in the retreatment of pulmonary tuberculosis.
    Tubercle; 1968 Mar; 49(1):70-8. PubMed ID: 5660586
    [No Abstract]   [Full Text] [Related]  

  • 44. The management of hypersensitivity reactions to antituberculosis drugs.
    Thompson JE
    Med J Aust; 1969 Nov; 2(21):1058-63. PubMed ID: 5373732
    [No Abstract]   [Full Text] [Related]  

  • 45. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 46. [Frequency of side-effects of tuberulostatics and its relation to the applied combination].
    Bethge W
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):258-65. PubMed ID: 4302238
    [No Abstract]   [Full Text] [Related]  

  • 47. [Toxico-allergic reactions in the use of antibacterial preparations in patients with tuberculosis of the lungs].
    Shapiro BIa
    Sov Med; 1965 Oct; 28(10):90-2. PubMed ID: 5895951
    [No Abstract]   [Full Text] [Related]  

  • 48. [Ethambutol combined with streptomycin and isoniazid for the original treatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hayashi N; Hibino S
    Kekkaku; 1970 Feb; 45(2):55-60. PubMed ID: 5439133
    [No Abstract]   [Full Text] [Related]  

  • 49. [Methemoglobinemia and hemolytic anemia caused by para-aminosalicylic acid (PAS) infusion therapy].
    Mastella G; Orlandi P; Garofalo E; Lorenzini E
    Fracastoro; 1966; 59(6):702-16. PubMed ID: 5301822
    [No Abstract]   [Full Text] [Related]  

  • 50. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 51. The detection of streptomycin, PAS and isoniazid resistant tubercle bacilli by the direct method.
    Stewart SM; Burnet ME
    Tubercle; 1968 Jun; 49(2):217-25. PubMed ID: 4969697
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effects of antitubercular agents on the fetus during therapy of tuberculous pregnant women].
    Ganguin G
    Z Erkr Atmungsorgane Folia Bronchol; 1971; 134(1):95-103. PubMed ID: 5209528
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immunity and allergy depression during rubella in a child with primary tuberculosis and isoniazid intolerance].
    Tournier G; Grunberg J; Hanoteau J; Gerbeaux J
    Ann Med Interne (Paris); 1972 Nov; 123(11):931-6. PubMed ID: 4540667
    [No Abstract]   [Full Text] [Related]  

  • 54. [Rheumatic diseases caused by antitubercular drugs].
    Anastasatu C; Stoia I; Kaufman S; Ghenoiu O; Iancovici O
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Jan; 136(1):51-63. PubMed ID: 4538033
    [No Abstract]   [Full Text] [Related]  

  • 55. Fungal infecton of central nervous system supervening during routine chemotherapy for pulmonary tuberculosis.
    Spens N; Tattersall WH
    Br Med J; 1965 Oct; 2(5466):862. PubMed ID: 5827803
    [No Abstract]   [Full Text] [Related]  

  • 56. In Canada: a trial of chemoprophylaxis in inactive tuberculosis.
    Grzybowski S; Ashley MJ; McKinnon NE; Pinkus G; Philipps R; Brown A
    Can Med Assoc J; 1969 Nov; 101(9):81-6. PubMed ID: 5348494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mechanism of action and effectiveness of intravenous administration of tubazid, streptomycin and PAS in the therapy of pulmonary tuberculosis].
    Pilipchuk NS; Ivaniuota OM; Kovalenko NN
    Probl Tuberk; 1970; 48(1):26-30. PubMed ID: 5425441
    [No Abstract]   [Full Text] [Related]  

  • 58. [Interaction of streptomycin, Tubazid and PAS according to myorelaxant and lethal effects].
    Soloviev NV; Berezhinskaia VV
    Antibiotiki; 1973 Mar; 18(3):249-52. PubMed ID: 4764220
    [No Abstract]   [Full Text] [Related]  

  • 59. [Morphological changes in the liver of guinea pigs with minor tubercular changes treated for a prolonged period with streptomycin, phthivazid and PASK].
    Rudaĭtene AP
    Probl Tuberk; 1970; 48(4):78-82. PubMed ID: 5528471
    [No Abstract]   [Full Text] [Related]  

  • 60. Serum transaminase levels during treatment with isoniazid, streptomycin and PAS.
    Smith JM; Springett VH
    Tubercle; 1966 Sep; 47(3):245-9. PubMed ID: 5971411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.